Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry

Showing results (191-200 of 312) with videos related to

Pageof 32
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2022
Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases that Drive Postischemic AngiogenesisJuan A Azcona, Samantha Tang, Elizabeth Berry, et al.
Journal of Autism and Developmental Disorders|October 6, 2011
Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatmentStephanie M Sansone, Keith F Widaman, Scott S Hall, et al.
Journal of Neurodevelopmental Disorders|September 8, 2016
The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directionsDavid Hessl, Stephanie M Sansone, Elizabeth Berry-Kravis, et al.
Pediatrics|August 18, 2017
FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X SyndromeStephanie L Sherman, Sharon A Kidd, Catharine Riley, et al.
Pulmonary Pharmacology & Therapeutics|October 26, 2018
Inhaled calcium salts inhibit tobacco smoke-induced inflammation by modulating expression of chemokines and cytokinesPaulette W Andreotta, Steve Arold, Jennifer Kenyon, et al.
Neurobiology of Disease|May 19, 2026
Cerebellar GABA and executive function among adult female carriers of the fragile X messenger ribonucleoprotein 1 premutation: a pilot study to examine neural underpinnings of the clinical phenotypeRoslyn Harold, Roma Kamat, Wei Siong Neo, et al.
BMC Pediatrics|June 5, 2026
The interactions between sleep difficulties and clinical features in children with rare genetic syndromes: a structural equation modelling approachRory O'Sullivan, Paul Thompson, Stacey Bissell, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trialsElizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Pediatric Neurology|July 15, 2020
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X SyndromeElizabeth Berry-Kravis, Joseph P Horrigan, Nicole Tartaglia, et al.
International Journal of Technology Assessment in Health Care|May 4, 2002
How to undertake a clinically relevant systematic review in a rapidly evolving field. Magnetic resonance angiographyMarie E Westwood, Steven Kelly, Elizabeth Berry, et al.
Pageof 32

Showing results (191-200 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2022
Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases that Drive Postischemic AngiogenesisJuan A Azcona, Samantha Tang, Elizabeth Berry, et al.
Journal of Autism and Developmental Disorders|October 6, 2011
Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatmentStephanie M Sansone, Keith F Widaman, Scott S Hall, et al.
Journal of Neurodevelopmental Disorders|September 8, 2016
The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directionsDavid Hessl, Stephanie M Sansone, Elizabeth Berry-Kravis, et al.
Pediatrics|August 18, 2017
FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X SyndromeStephanie L Sherman, Sharon A Kidd, Catharine Riley, et al.
Pulmonary Pharmacology & Therapeutics|October 26, 2018
Inhaled calcium salts inhibit tobacco smoke-induced inflammation by modulating expression of chemokines and cytokinesPaulette W Andreotta, Steve Arold, Jennifer Kenyon, et al.
Neurobiology of Disease|May 19, 2026
Cerebellar GABA and executive function among adult female carriers of the fragile X messenger ribonucleoprotein 1 premutation: a pilot study to examine neural underpinnings of the clinical phenotypeRoslyn Harold, Roma Kamat, Wei Siong Neo, et al.
BMC Pediatrics|June 5, 2026
The interactions between sleep difficulties and clinical features in children with rare genetic syndromes: a structural equation modelling approachRory O'Sullivan, Paul Thompson, Stacey Bissell, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trialsElizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Pediatric Neurology|July 15, 2020
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X SyndromeElizabeth Berry-Kravis, Joseph P Horrigan, Nicole Tartaglia, et al.
International Journal of Technology Assessment in Health Care|May 4, 2002
How to undertake a clinically relevant systematic review in a rapidly evolving field. Magnetic resonance angiographyMarie E Westwood, Steven Kelly, Elizabeth Berry, et al.
Pageof 32